These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 20414837

  • 1. Targeting receptor antibodies in immune cardiomyopathy.
    Jahns R, Schlipp A, Boivin V, Lohse MJ.
    Semin Thromb Hemost; 2010 Mar; 36(2):212-8. PubMed ID: 20414837
    [Abstract] [Full Text] [Related]

  • 2. Pathological autoantibodies in cardiomyopathy.
    Jahns R, Boivin V, Schwarzbach V, Ertl G, Lohse MJ.
    Autoimmunity; 2008 Sep; 41(6):454-61. PubMed ID: 18781471
    [Abstract] [Full Text] [Related]

  • 3. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I.
    Circ Res; 2011 Oct 14; 109(9):986-92. PubMed ID: 21868696
    [Abstract] [Full Text] [Related]

  • 4. Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.
    Haberland A, Wallukat G, Schimke I.
    Trends Cardiovasc Med; 2011 Aug 14; 21(6):177-82. PubMed ID: 22814426
    [Abstract] [Full Text] [Related]

  • 5. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.
    Nikolaev VO, Boivin V, Störk S, Angermann CE, Ertl G, Lohse MJ, Jahns R.
    J Am Coll Cardiol; 2007 Jul 31; 50(5):423-31. PubMed ID: 17662395
    [Abstract] [Full Text] [Related]

  • 6. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
    Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R.
    Am Heart J; 2006 Oct 31; 152(4):697-704. PubMed ID: 16996841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R, Boivin V, Lohse MJ.
    Int J Cardiol; 2006 Sep 10; 112(1):7-14. PubMed ID: 16872696
    [Abstract] [Full Text] [Related]

  • 10. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
    Jahns R, Boivin V, Lohse MJ.
    Trends Cardiovasc Med; 2006 Jan 10; 16(1):20-4. PubMed ID: 16387626
    [Abstract] [Full Text] [Related]

  • 11. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.
    Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ.
    J Clin Invest; 2004 May 10; 113(10):1419-29. PubMed ID: 15146239
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S.
    Autoimmunity; 2008 Feb 10; 41(1):35-45. PubMed ID: 18176863
    [Abstract] [Full Text] [Related]

  • 13. Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyopathic changes.
    Matsui S, Fu M, Hayase M, Katsuda S, Yamaguchi N, Teraoka K, Kurihara T, Murano H, Takekoshi N.
    Autoimmunity; 2006 Mar 10; 39(2):121-8. PubMed ID: 16698668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiomyopathy - An approach to the autoimmune background.
    Becker NP, Müller J, Göttel P, Wallukat G, Schimke I.
    Autoimmun Rev; 2017 Mar 10; 16(3):269-286. PubMed ID: 28163240
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.
    Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U.
    J Mol Cell Cardiol; 2001 Aug 10; 33(8):1515-25. PubMed ID: 11448139
    [Abstract] [Full Text] [Related]

  • 17. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study.
    Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio AL, Felix SB, Fu M, Katus H, Angermann CE, Lohse MJ, Ertl G, Störk S, Jahns R, Etiology, Titre-Course, and Survival-Study Group.
    Eur J Heart Fail; 2010 Jul 10; 12(7):753-62. PubMed ID: 20494925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies.
    Dragun D, Philippe A, Catar R, Hegner B.
    Thromb Haemost; 2009 Apr 10; 101(4):643-8. PubMed ID: 19350106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.